Echo Therapeutics, Inc. ECTE

Set alert

Price alert · ECTE

All alert types
0.00 0.00 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
0
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
More statistics
Low
—
High
—

3M chart

Chart tools
Interval

Chart is warming up

The three-month price history for ECTE has not been loaded yet. Try again in a moment.

Revenue & Expenses

Revenue → Gross Profit: $57.32KGross Profit → Expenses: $57.32KExpenses → Selling, General & Admin: $7.42MExpenses → Research & Development: $4.96MExpenses → Other Expenses: $2.64MExpenses → Income Tax: $4.00KNet Loss → Expenses: $14.96MGross Profit$57.32KNet Loss$14.96MExpenses$15.02MSelling, General & Admin$7.42MResearch & Development$4.96MOther Expenses$2.64MIncome Tax$4.00KRevenue$57.32K

Latest period ending Dec 31, 2015 · select a line to chart its full history

ECTE annual income statement
Fiscal yearFY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013FY 2012 Dec 31, 2012FY 2011 Dec 31, 2011
-17.54M-12.32M-19.64M-15.04M-8.25M
-22.20M-14.96M-19.07M-12.33M-10.03M
-1.98-1.24-2.33-3.12-4.89
ECTE annual balance sheet
Fiscal yearFY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013FY 2012 Dec 31, 2012FY 2011 Dec 31, 2011
292.63K1.33M8.37M4.16M9.27M
805.09K12.60M23.09M20.02M19.53M
3.33M3.07M3.72M9.79M2.56M
330.00K01.36K124.72K6.18K
-2.53M9.52M19.37M10.23M16.97M
ECTE annual cash flow
Fiscal yearFY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013FY 2012 Dec 31, 2012FY 2011 Dec 31, 2011
-5.08M-10.72M-19.41M-10.29M-6.93M
-113.69K215.45K-144.03K-1.64M-317.79K
3.97M3.73M23.86M6.68M14.90M
70.25K-36.63K-249.01K-1.49M-323.30K
-1.22M-6.78M4.31M-5.25M7.65M